Temporal differences in gamma-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki: A retrospective study

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Volumn 20, Issue , 2012, Pages

  Boyd, James J ^a   Kuisma, Markku J ^a   Randell, Tarja T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Emergency medical services; Gamma hydroxybutyric acid; Overdose

Indexed keywords

GAMMA BUTYROLACTONE; OXYBATE SODIUM; STREET DRUG;

ADDICTION; ADULT; ARTICLE; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; FEMALE; FINLAND; HUMAN; INTOXICATION; MALE; RETROSPECTIVE STUDY; STATISTICS; SUBSTANCE ABUSE; URBAN POPULATION;

4-BUTYROLACTONE; ADULT; EMERGENCY MEDICAL SERVICES; FEMALE; FINLAND; HUMANS; MALE; OVERDOSE; RETROSPECTIVE STUDIES; SODIUM OXYBATE; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION; YOUNG ADULT;

EID: 84856405469     PISSN: None     EISSN: 17577241     Source Type: Journal    
DOI: 10.1186/1757-7241-20-7     Document Type: Article

References (22)

1. Dietze PM, Cvetkovski S, Barratt MJ, Clemens S. Patterns and incidence of gamma-hydroxybutyrate (GHB)-related ambulance attendances in Melbourne, Victoria. Med J Aust 2008, 188:709-711.
2. West E, Cameron P, O'Reilly G, Drummer OH, Bystrzycki A. Accuracy of current clinical diagnosis in recreational drug-related attendance to the emergency department. Emerg Med Australas 2008, 20:333-338.
3. Snead OC, Gibson KM. Gamma-hydroxybutyric acid. N Eng J Med 2005, 352:2721-2732.
4. Li J, Stokes SA, Woeckener A. A tale of novel intoxication: Seven cases of gamma-hydroxybutyric acid overdose. Ann Emerg Med 1998, 31:723-728.
5. Munir VL, Hutton JE, Harney JP, Buykx P, Weiland TJ, Dent AW. Gamma-hydroxybutyrate: A 30 month emergency department review. Emerg Med Australas 2008, 20:521-530.
6. Kelly BC, Parsons JT, Wells BE. Prevalence and predictors of club drug use among club-going young adults in New York City. J Urban Health 2006, 83:884-895.
7. Liechti ME, Kunz I, Greminger P, Speich R, Kupferschmidt H. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend 2006, 81:323-326.
8. Miro O, Nogue S, Espinosa G, To-Figueras J, Sanchez M. Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. J Toxicol Clin Toxicol 2002, 40:129-135.
9. Ruttenber AJ, Luke JL. Heroin-related deaths: New epidemiologic insights. Science 1984, 226:14-20.
10. Manfredini R, Gallerani M, Calo G, Pasin M, Govoni M, Fersini C. Emergency admission of opioid abusers for overdose: A chronobiological study of enhanced risk. Ann Emerg Med 1994, 24:615-618.
11. Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, Clarke S, Ramsey J, Holt DW, Dargan PI. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1, 4BD). Q J Med 2008, 101:23-29.
12. Boyd CJ, McCabe SE, d'Arcy H. Ecstasy use among collage undergraduates: Gender, race and sexual identity. J Subst Abuse Treat 2003, 24:209-215.
13. Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance use among young people: The relationship between perceived functions and intentions. Addiction 1999, 94:1043-1050.
14. Liechti ME, Gamma A, Vollenweider FX. Gender differences in the subjective effects of MDMA. Psychopharmacol 2001, 154:161-168.
15. Anderson IB, Kim SY, Dyer JE, Burkhardt CB, Iknoian JC, Walsh MJ, Blanc PD. Trends in γ-Hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Ann Emerg Med 2006, 47:177-183.
16. Tammi T, Pitkänen T, Perälä J. Stadin nistit- huono-osaisten helsinkiläisten huumeidenkäyttäjien päihteet sekä niiden käyttötavat ja hankinta. Yhteiskuntapolitiikka 2011, 76:45-54. (abstract in English).
17. European monitoring centre for drugs and drug addiction (EMCDDA). 2011, http://www.emcdda.europa.eu/publications/country-overviews/fi Situation summary: Problem drug use. Last accessed July 3rd.
18. European monitoring centre for drugs and drug addiction (EMCDDA). 2011, http://www.emcdda.europa.eu/publications/country-overviews/fi. Situation summary: Drug related deaths. Last accessed July 3rd.
19. Alho H, Sinclair D, Vuori E, Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 2007, 88:75-78.
20. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Eng Med J 2005, 353:1945-1954.
21. Metraux S, Metzger DS. Homelessness and HIV risk behaviors among injection drug users. J Urban Health 2004, 81:618-629.
22. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II Responses to overdose. Addiction 1996, 91:413-417.